AzTrials
AzTrials

Trauma (Including Fractures)Phase 4InfrapectinealNCT07170280

Evaluation of Direct Infrapectineal Plating in Quadrilateral Plate Acetabular Fractures

A Phase 4 study testing Direct Infrapectineal Plating in Quadrilateral Plate Acetabular Fractures: A Prospective Cohort Study in people with Trauma (Including Fractures), run by Mahmoud Fahmy at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to evaluate the outcomes of direct infrapectineal plate fixation in patients with quadrilateral plate acetabular fractures. A total of 25 adult patients with acute fractures were enrolled between 2021 and 2024 at a university-affiliated hospital. Read more about this study

Who is it for?
Ages 18 to 64 years
Conditions the study is for
Trauma (Including Fractures)
What is being tested?
Direct Infrapectineal Plating in Quadrilateral Plate Acetabular Fractures: A Prospective Cohort Study
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
1 siteEgypt
Study dates
1 Jan 2021to 1 Jan 2024
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 64 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Acute quadrilateral plate acetabular fractures (≤3 weeks from injury).
  • Medically fit for surgery under general or regional anesthesia.
  • Patients willing to participate and provide informed consent. -
  • Exclusion Criteria:Pathological fractures (e.g., metastatic or metabolic).
  • Pre-existing ipsilateral hip pathology affecting radiological or functional outcomes.
  • Delayed presentation: injury >4 weeks before surgery.
Show all 9Show fewer
  • Medical contraindications to surgery (e.g., unstable comorbidities).
  • Polytrauma patients with hemodynamic instability.
  • -

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo University

    Cairo, Cairo Governorate, 11562

Other trials in Egypt

About this study

Official title: Radiological and Functional Evaluation of Direct Infrapectineal Plating in Quadrilateral Plate Acetabular Fractures: A Prospective Cohort Study

This study aims to evaluate the outcomes of direct infrapectineal plate fixation in patients with quadrilateral plate acetabular fractures. A total of 25 adult patients with acute fractures were enrolled between 2021 and 2024 at a university-affiliated hospital. All patients underwent surgical fixation through the ilioinguinal approach. Radiological results were assessed using the Matta scoring system, and functional outcomes were evaluated using the Merle d'Aubigné and Postel scoring system. The study further assessed complication rates, operative time, intraoperative blood loss, and hospital stay.

Read the detailed description

Quadrilateral plate acetabular fractures are complex injuries that present challenges in achieving stable fixation due to their anatomical location and high risk of medial displacement. The direct infrapectineal plate, applied via the ilioinguinal approach, offers a biomechanically stable construct for buttressing the medial acetabular wall.

This prospective cohort study enrolled 25 patients aged 18-64 years with acute quadrilateral plate acetabular fractures between January 2021 and January 2024. Patients with pathological fractures, pre-existing ipsilateral hip disease, or delayed presentation (>4 weeks) were excluded.

The surgical procedure involved direct infrapectineal plating through the ilioinguinal approach. Radiological outcomes were measured using the Matta scoring system, and functional results were assessed with the Merle d'Aubigné and Postel scoring system at a mean follow-up of 14.7 months. Secondary measures included operative time, blood loss, hospital stay, and complication profile.

Preliminary results showed that anatomical reduction was achieved in 64% of patients, with excellent or good functional results in 68%. The complication rate was low, with only one case of deep infection requiring implant removal.

The study concludes that infrapectineal plating provides stable fixation with favorable functional and radiological outcomes for quadrilateral plate acetabular fractures.

Being tested
Direct Infrapectineal Plating in Quadrilateral Plate Acetabular Fractures: A Prospective Cohort Study
Keywords
Acetabular fracture, Surgical fixation, Quadrilateral plate, Ilioinguinal approach
Medical subject headings
Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Direct Infrapectineal Plating in Quadrilateral Plate Acetabular Fractures: A Prospective Cohort StudyProcedure or surgery

    This study aims to evaluate the outcomes of direct infrapectineal plate fixation in patients with quadrilateral plate acetabular fractures. A total of 25 adult patients with acute fractures were enrolled between 2021 and 2024 at a university-affiliated hospital. All patients underwent surgical fixation through the ilioinguinal approach. Radiological results were assessed using the Matta scoring system, and functional outcomes were evaluated using the Merle d'Aubigné and Postel scoring system. The study further assessed complication rates, operative time, intraoperative blood loss, and hospital stay.

Study groups in NCT07170280
Study groupRoleWhat they receive
Radiological and Functional Evaluation of Direct Infrapectineal Plating in Quadrilateral Plate AcetaOtherQuadrilateral plate acetabular fractures are complex injuries that present challenges in achieving stable fixation due to their anatomical location and high risk of medial displacement. The direct infrapectineal plate, applied via the ilioinguinal approach, offers a biomechanically stable construct for buttressing the medial acetabular wall. This prospective cohort study enrolled 25 patients aged 18-64 years with acute quadrilateral plate acetabular fractures between January 2021 and January 2024. Patients with pathological fractures, pre-existing ipsilateral hip disease, or delayed presentation (>4 weeks) were excluded. The surgical procedure involved direct infrapectineal plating through the ilioinguinal approach. Radiological outcomes were measured using the Matta scoring system, and functional results were assessed with the Merle d'Aubigné and Postel scoring system at a mean follow-up of 14.7 months. Secondary measures included operative time, blood loss, hospital stay, and comp
Receives: Procedure: Direct Infrapectineal Plating in Quadrilateral Plate Acetabular Fractures: A Prospective Cohort Study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Radiological and Functional Evaluation of Direct Infrapectineal Plating in Quadrilateral Plate Acetabular Fractures: A Prospective Cohort Study

    Primary Outcome Measures

    Description: Radiographic assessment using the Matta scoring system at long-term follow-up.

    Time Frame: monthly till 4 years postoperatively

    Description: Postoperative anteroposterior and Judet pelvic radiographs assessed using the Matta scoring system. Reduction quality classified as anatomical (0-1 mm displacement), imperfect (2-3 mm), or poor (>3 mm).Radiological outcome at long-term follow-up

    Unit of Measure: Number of patients per reduction category

    Measured: 4 years

Secondary outcomes (1)
  1. Radiological and Functional Evaluation of Direct Infrapectineal Plating in Quadrilateral Plate Acetabular Fractures: A Prospective Cohort Study

    Functional outcome (Merle d'Aubigné and Postel scoring system)

    Time Frame: monthly till 4 years postoperatively Description: Functional evaluation of hip pain, mobility, and walking ability using the Merle d'Aubigné and Postel scoring system. Outcomes categorized as excellent, good, fair, or poor.

    Unit of Measure: Number of patients per functional category

    Measured: 4 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Sep 2025
  2. Study start1 Jan 2021
  3. Primary completion1 Jan 2024
  4. Study completion1 Jan 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Quadrilateral plate acetabular fractures are complex injuries that present challenges in achieving stable fixation due to their anatomical location and high risk of medial displacement. The direct infrapectineal plate, applied via the ilioinguinal approach, offers a biomechanically stable construct for buttressing the medial acetabular wall. This prospective cohort study enrolled 25 patients aged 18-64 years with acute quadrilateral plate acetabular fractures between January 2021 and January 2024. Patients with pathological fractures, pre-existing ipsilateral hip disease, or delayed presentation (\>4 weeks) were excluded. The surgical procedure involved direct infrapectineal plating through the ilioinguinal approach. Radiological outcomes were measured using the Matta scoring system, and functional results were assessed with the Merle d'Aubigné and Postel scoring system at a mean follow-up of 14.7 months. Secondary measures included operative time, blood loss, hospital stay, and compl
Masking
None (open label)
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07170280
Sponsor's protocol ID
MD-350-2021
Acronym
Infrapectineal
Status last verified
Sep 2025
First submitted
29 Aug 2025
Last updated
12 Sep 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data (e.g., baseline demographics, intraoperative details, postoperative outcomes, functional and radiological scores) that underlie the results reported in the publication will be shared. No direct identifiers will be included.

Publications

  • Fahmy M, Sadek FZ, Abdel Karim M, Fadel MH, Gobba M. Quadrilateral plate acetabular fractures: radiological and functional outcomes of direct infrapectineal plating. Int Orthop. 2026 Jul;50(7):1749-1757. doi: 10.1007/s00264-026-06882-4. Epub 2026 Jun 3.

    PubMed 42234014

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Direct Infrapectineal Plating in Quadrilateral Plate Acetabular Fractures: A Prospective Cohort Study in people with Trauma (Including Fractures), run by Mahmoud Fahmy at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Radiological and Functional Evaluation of Direct Infrapectineal Plating in Quadrilateral Plate Acetabular Fractures: A Prospective Cohort Study (time frame: 4 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07170280, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in